New MS drug trial uses powerful 7T MRI to see inside the brain
Disease control
Not yet recruiting
This study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo ultra high-field 7T MRI scans to measure brain changes. The goal is to see if the drug can …
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated May 15, 2026 11:53 UTC